Greg call. Crawford, you all I'm for us My operator, name Chief you, the is and Quipt and thank Chairman Thank of Home and today the joining Officer on Executive Medical.
the is our home of is of company, across homes Joining Hardik me States. their Home care a Quipt providing Financial medical Medical equipment today own diversified services comfort health United Mehta, in the Chief and spectrum Officer. services full a patients to
At conjunction centered Quipt, excellence equipment at best needs. way that drive this delivering leveraging our suits our to their in and a treat with solutions programs specialized we clinical technology-enabled our patient-centric respiratory effectively ecosystem, is through in home around model patients clinical
our mix At cardio XX% of pulmonary with of meeting care, the dedication product present, needs those respiratory is dedicated and conditions. reflecting approximately our to to
the driving our Our remarkable exceeding an behind superior over X,XXX to patient our success, to team bringing life commitment force is vision unyielding with daily care.
resilient We continue to model. business our results financial and by achieve consistent driven operational
revenue representing solutions is the we our and strategies fiscal of driving offer the end-to-end recurring strength sits at our the QX, and respiratory go-to-market As total of of deploy targeted revenue growth marketplace. foundation. in our XX% predictability share market Moreover, we financial base
patients, states a and XXX coast reach has With Quipt to strong coast. across over XXX,XXX from XX active locations
redundancy, monitor obtained increase able With and effectively, we our our organizational reduce have and been the expanding margins. patient scale base constantly grow to we
real-time XXXX see we and update strong our product on we quarter performance. to in continuing On categories of our across insights our continued on record-breaking first the this call, business. are you The success our trends strategic fiscal will demand core
continue revenue or build of across with $XX.X we During adjusted record strong fiscal momentum of $XX.X business, million XXXX, growth to equating or XX%. recording of the QX EBITDA XX.X%, to million XX% year-over-year margin growth of
are consistent drive we in economies profile We cost scale and effective margin the our strategies. business our strength seeing implement as in of management
on capitalizing efforts very Our COPD, of supply reach us and extending touch on offerings, continuum chain regulatory strategic enhancing cross-selling navigating conducive these product emphasis with targeted strategically a expanding markets. care, in a our prevalence within We've higher our stable the has and our our landscape sales a areas of positioned well. vital points
growth. In adults persistent the and affects States, our it. do a This not significant COPD key they is driver million estimated XX of it's nearly know have more population that many patient United
needs we poised meeting As a an we of progress for XX%. to our also dedication but fiscal of our only through XXXX, initiatives, of X% not achieve evolving to the rate patient annualized consistent organic exceeding of of are This and sustained remainder trajectory and is strategic aiming the growth our reflection to growth population.
organic plan, mix product long-term a our with our factor success centers. offices, of is continue essential agencies our which we physician's respiratory hospitals, growth, maintaining end-to-end our medical facilities strategic sales our volume and total boost and can include We to which care the growth facilities, implement primary the of on offering by markets. solutions expansion in channels, focusing rehab our is range full varied home core key of long-term driver of growth Additionally, to a approach health like key
segment and within demand and trends market update our the diabetes reaction sleep of provide are Despite we will to an loss to business. foreseeable our to speculation confidently continued well adoption Moreover, concerning anticipation persist the GLP-X medications, that strengths our I future. unaffected. am into sleep real that Demand remain is and exhibit this time, the seeing continued patterns I the pleased in can on ongoing weight report
manufacturer data to devices a an published from therapy. frequently. in largest study that industry between patients that findings supplies therapy and showed are sleep real-world of the PAP and more GLP-X actually a correlation more GLP-Xs prescribe and The were the significant Recently, diagnosis OSA order PAP with positive likely their initiate
accepted care it apnea. to patients is stress with for therapy obstructive Gold BiPAP critical the CPAP of In that addition, and remain sleep Standard
represents future received believe firmly yet significant we expansion. XX but for diagnosis, unrealized over which a potential that Americans a market million have not Furthermore, have OSA,
now, more and market. the As lead we in addressable could diagnosis a awareness of right OSA overall think to that rise rising
we least, sleep think patients segment thing focused most therapy, not on sleep with collaborate their is the our adherence the to but important to Last is still ensure to that foundation which our of compliance.
signs Looking regulatory to suggesting a prices about started CMS at return have competitive no and we past, ongoing the In competitive months to all bidding the procedures and finalized. landscape, are bidding. XX seen has contracts stability continue before see
the easing home we reduces that the oxygen seen restrictions such positive administrative burden of up access to in patients. have providers developments past opens health for look we As and on policy year, as care the
in Quipt the setting patients to with is our to home the services, supplying in potential positioned in respiratory nature States across products and viable the business, well the any economy. thrive of downturns Due United involves which
put of strong our proactive markets our Our foundation along strategy, throughout the implement go-to-market on the innovative strategy with through proceed fiscal growth infrastructure our to to additional position country. a we XXXX. We focus driving inorganic, have on attractive plan to strategic up both opening of pillars continue forward operational and strength developing fundamental as in approach a steadfast and us organic
call With that to financial commentary, I'd XXXX first results. to fiscal quarter discuss Hardik the hand like over to our
